NUTX (STOCKS)
Nutex Health Inc. Common Stock
$103.000000
+1.620000 (+1.60%)
Prev close: $101.380000
Company Information
- Exchange
- XNAS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Thomas T. Vo
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $739.20M
- Employees
- 830
- P/E (TTM)
- 5.26
- P/B (TTM)
- 2.21
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$7.76 | $1.11 | +6.6482 | +597.97% |
|
Jun 2025 (Q2)
|
$-2.95 | $-2.93 | -0.0226 | -0.77% |
|
Mar 2025 (Q1)
|
$2.56 | $2.34 | +0.2242 | +9.60% |
|
Dec 2024 (Q4)
|
$11.12 | $-0.13 | +11.2458 | +8,939.43% |
Financial Statements
| Revenues | $981.20M |
| Benefits Costs and Expenses | $653.73M |
| Cost Of Revenue | $441.43M |
| Costs And Expenses | $474.47M |
| Gross Profit | $539.77M |
| Operating Expenses | $180.85M |
| Operating Income/Loss | $358.92M |
| Income/Loss From Continuing Operations After Tax | $263.72M |
| Income/Loss From Continuing Operations Before Tax | $327.46M |
| Income Tax Expense/Benefit | $63.75M |
| Income Tax Expense/Benefit, Deferred | $11.55M |
| Net Income/Loss | $263.72M |
| Net Income/Loss Attributable To Noncontrolling Interest | $143.07M |
| Net Income/Loss Attributable To Parent | $120.65M |
| Net Income/Loss Available To Common Stockholders, Basic | $120.65M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $21.46 |
| Diluted Earnings Per Share | $19.99 |
| Basic Average Shares | 6,242,195 |
| Diluted Average Shares | 7,134,933 |
| Assets | $964.52M |
| Current Assets | $592.65M |
| Inventory | $3.16M |
| Other Current Assets | $589.49M |
| Noncurrent Assets | $371.87M |
| Fixed Assets | $82.82M |
| Intangible Assets | $21.56M |
| Other Non-current Assets | $267.49M |
| Liabilities | $526.49M |
| Current Liabilities | $185.46M |
| Noncurrent Liabilities | $341.03M |
| Equity | $438.03M |
| Equity Attributable To Noncontrolling Interest | $120.87M |
| Equity Attributable To Parent | $317.17M |
| Liabilities And Equity | $964.52M |
| Net Cash Flow From Operating Activities | $177.79M |
| Net Cash Flow From Operating Activities, Continuing | $177.79M |
| Net Cash Flow From Investing Activities | -$565.22K |
| Net Cash Flow From Investing Activities, Continuing | -$565.22K |
| Net Cash Flow From Financing Activities | -$55.14M |
| Net Cash Flow From Financing Activities, Continuing | -$55.14M |
| Net Cash Flow | $122.08M |
| Net Cash Flow, Continuing | $122.08M |
| Comprehensive Income/Loss | $263.72M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $263.72M |
| Other Comprehensive Income/Loss | $0.00 |